B Smith’s scientific contributions

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (1)


Drug and Vaccine Development for Infectious Diseases: The Value of Priority Review Vouchers
  • Article

July 2009

·

26 Reads

·

8 Citations

Clinical Pharmacology & Therapeutics

·

B Smith

·

·

M Mair

Citations (1)


... Regulators' adjusting clinical and pharmacogenetic criteria could incentivise OD R&D in particular disease areas of high unmet need [81]. However, PRVs partly do this already [86], offering specific ODs faster approval and longer exclusivities. Others suggest competitive price reduction could provide 'downward pressure to both decrease costs and improve clinical outcomes… [with] only one drug in each class [being granted].the ...

Reference:

Debates over orphan drug pricing: a meta-narrative literature review
Drug and Vaccine Development for Infectious Diseases: The Value of Priority Review Vouchers
  • Citing Article
  • July 2009

Clinical Pharmacology & Therapeutics